Related Experiment Video
Updated: Jan 12, 2026

Frailty Assessment in an Aging Mouse Model
Published on: September 23, 2025
Association between frailty and gout in middle-aged and older adults: A nationwide cross-sectional and Mendelian
Yuan Sun1, Wenli Liu2, Delun Li2
1School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China.
Abstract:
With the aging population, frailty is becoming increasingly prevalent among older adults, yet its association with gout, a common form of arthritis affecting middle-aged and older adults, remains unclear. This study investigated the frailty-gout relationship through a nationwide cross-sectional analysis combined with Mendelian randomization (MR). Data from 22,324 adults aged 40 and above in the National Health and Nutrition Examination Survey (NHANES, 2007-2018) were analyzed utilizing survey-weighted logistic regression models. Genome-wide association study data from UK Biobank, TwinGen, and FinnGen were utilized to explore genetic correlations and causality. The cross-sectional study indicated a significant relationship between pre-frail (odds ratio [OR] = 2.33, 95% confidence interval [CI] = 1.76-3.08, P < .0001) and frail (OR = 4.63, 95% CI = 3.67-5.84, P < .0001) individuals and gout. This association persisted after comprehensive covariate adjustment (pre-frail OR = 2.13, 95% CI = 1.59-2.85, P < .0001; frail OR = 4.11, 95% CI = 3.16-5.35, P < .0001). The interaction effect between frailty and gout was significantly influenced by race/ethnicity (P interaction = .0046) and gender (P interaction = 6.72 × 10-6). Linkage disequilibrium score regression analysis demonstrated a moderate yet significant genetic correlation between the frailty index and gout (rg = 0.319, standard error (SE) = 0.042, P = 2.19 × 10-14). MR analysis confirmed a causal link between frailty index and gout (OR = 2.29, 95% CI = 1.45-3.62, P < .001), while reverse MR analysis indicated no causality. These findings elucidated frailty as a risk factor for gout, underscoring the necessity for uric acid monitoring to mitigate gout risk in frail individuals, potentially informing sustained healthcare initiatives for gout in middle-aged and older adults.
More Related Videos
04:00Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles
Published on: July 26, 2024
05:53Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Pharmacodynamics in Geriatric Patients: Effects of Age
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism